NantHealth Overview
Latest ROE for NantHealth: 28.13% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow28.13%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, NH shows a ROE of 28.13%. That is below the Technology sector average of 46.88%. Scroll down for historical charts and peer comparison views.
The Technology sector average ROE is about 46.88%. NantHealth is at 28.13%, which is lower that average. That is roughly 40.0% below the sector mean. Use the comparison chart on this page to see how NH stacks up against individual peers as well.
Check the historical chart to see whether NH's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare NantHealth with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has NantHealth's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 28.13%) with ownership activity and broader fundamentals.
The Technology average ROE is about 46.88%, while NH is at 28.13%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
